There are obvious problems with KSX at the moment-we are all painfully aware of that!Looking at performance of small caps on the ASX over the last eighteen months,one can appreciate how many others are struggling:low volumes,poor responses to good announcements and generally investor indifference.No doubt algorithmic trading has made technical analysis very unreliable now.[expert chartist I am not]It all means that its becoming a 'needle in the haystack' exercise. KSX could be that 'needle':it really has greater potential than many others-this is hard to realize when the top brass underwhelm with their performance but the future is there.In the 'Mail' today was this headline:"Cancer sufferers 'to be given chemotherapy at branches of Boots' in extraordinary shake-up of NHS". As I have previously mentioned,it is the outsourcing of hospital treatments for chronic conditions that holds great promise for outfits like KSX.The bonus is that KSX's technology is unique and the competition will be lagging behind if outsourcing really take off.
Cheers to all
KSX Price at posting:
2.0¢ Sentiment: LT Buy Disclosure: Held